{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:08:05Z","timestamp":1772755685670,"version":"3.50.1"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T00:00:00Z","timestamp":1393545600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0089392","type":"journal-article","created":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T21:42:07Z","timestamp":1393623727000},"page":"e89392","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Interferon-Gamma (IFN-\u03b3)-Mediated Retinal Ganglion Cell Death in Human Tyrosinase T Cell Receptor Transgenic Mouse"],"prefix":"10.1371","volume":"9","author":[{"given":"Shahid","family":"Husain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasir","family":"Abdul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilpak","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pravin","family":"Kesarwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shikhar","family":"Mehrotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,2,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.exer.2010.04.002","article-title":"Mechanisms of retinal ganglion cell injury and defense in glaucoma","volume":"91","author":"J Qu","year":"2010","journal-title":"Exp Eye Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.preteyeres.2003.12.001","article-title":"Retinal ischemia: mechanisms of damage and potential therapeutic strategies","volume":"23","author":"NN Osborne","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.exer.2008.11.003","article-title":"The genetics of primary open-angle glaucoma: a review","volume":"88","author":"RR Allingham","year":"2009","journal-title":"Exp Eye Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.exer.2010.08.016","article-title":"The case for autoimmunity in glaucoma","volume":"93","author":"MB Wax","year":"2011","journal-title":"Exp Eye Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1350-9462(98)00014-7","article-title":"Neuronal death in glaucoma","volume":"18","author":"HA Quigley","year":"1999","journal-title":"Prog Retin Eye Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.preteyeres.2011.11.002","article-title":"The molecular basis of retinal ganglion cell death in glaucoma","volume":"31","author":"M Almasieh","year":"2012","journal-title":"Prog Retin Eye Res"},{"key":"ref7","first-page":"1077","article-title":"Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension","volume":"43","author":"SJ McKinnon","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1167\/iovs.07-1032","article-title":"Effect of IL-1beta on survival and energy metabolism of R28 and RGC-5 retinal neurons","volume":"49","author":"SF Abcouwer","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1089\/152308603770310293","article-title":"Amplification of a reactive oxygen species signal in axotomized retinal ganglion cells","volume":"5","author":"SM Nguyen","year":"2003","journal-title":"Antioxid Redox Signal"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.preteyeres.2006.07.003","article-title":"Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences","volume":"25","author":"G Tezel","year":"2006","journal-title":"Prog Retin Eye Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1172\/JCI42440","article-title":"A look at autoimmunity and inflammation in the eye","volume":"120","author":"RR Caspi","year":"2010","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ni1328","article-title":"See no evil, hear no evil, do no evil: the lessons of immune privilege","volume":"7","author":"JY Niederkorn","year":"2006","journal-title":"Nat Immunol"},{"key":"ref13","first-page":"2201","article-title":"Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor","volume":"32","author":"SW Cousins","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/1531-8249(200001)47:1<9::AID-ANA5>3.0.CO;2-I","article-title":"Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration","volume":"47","author":"ML Albert","year":"2000","journal-title":"Ann Neurol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.272.5258.50","article-title":"The instructive role of innate immunity in the acquired immune response","volume":"272","author":"DT Fearon","year":"1996","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.4049\/jimmunol.158.3.1428","article-title":"Local-clonal expansion of infiltrating T lymphocytes in chronic encephalitis of Rasmussen","volume":"158","author":"Y Li","year":"1997","journal-title":"J Immunol"},{"key":"ref17","first-page":"6230","article-title":"MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyte","volume":"59","author":"MI Nishimura","year":"1999","journal-title":"Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.4049\/jimmunol.1103271","article-title":"A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice","volume":"189","author":"S Mehrotra","year":"2012","journal-title":"J Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1167\/iovs.12-9467","article-title":"Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model","volume":"53","author":"S Husain","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1167\/iovs.12-10741","article-title":"Delta-Opioid Agonist SNC-121 Protects Retinal Ganglion Cell Function in a Chronic Ocular Hypertensive Rat Model","volume":"54","author":"Y Abdul","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1167\/iovs.08-2907","article-title":"Opioid receptor-activation: retina protected from ischemic injury","volume":"50","author":"S Husain","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1167\/iovs.10-5629","article-title":"Opioid receptor activation: suppression of ischemia\/reperfusion-induced production of TNF-alpha in the retina","volume":"52","author":"S Husain","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1350-9462(00)00030-6","article-title":"Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis","volume":"20","author":"GE Holder","year":"2001","journal-title":"Prog Retin Eye Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.4049\/jimmunol.0902778","article-title":"Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice","volume":"184","author":"RK Gregg","year":"2010","journal-title":"J Immunol"},{"key":"ref25","first-page":"74","article-title":"Possible mechanisms in the induction of vitiligo-like hypopigmentation by topical imiquimod","volume":"33","author":"J Mashiah","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"JG van den Boorn","year":"2009","journal-title":"J Invest Dermatol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e18907","DOI":"10.1371\/journal.pone.0018907","article-title":"Th17 cells and activated dendritic cells are increased in vitiligo lesions","volume":"6","author":"CQ Wang","year":"2011","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1350-9462(99)00017-8","article-title":"The optic nerve head in glaucoma: role of astrocytes in tissue remodeling","volume":"19","author":"MR Hernandez","year":"2000","journal-title":"Prog Retin Eye Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/archopht.1997.01100150391013","article-title":"The optic nerve head in glaucomatous optic neuropathy","volume":"115","author":"MR Hernandez","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/archopht.1990.01070090122053","article-title":"Optic nerve head extracellular matrix in primary optic atrophy and experimental glaucoma","volume":"108","author":"JC Morrison","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/glia.20962","article-title":"Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss","volume":"58","author":"JL Son","year":"2010","journal-title":"Glia"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1124\/jpet.113.203067","article-title":"Neuroprotective effects of cilostazol on retinal ganglion cell damage in diabetic rats","volume":"345","author":"KI Jung","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1440-1789.2002.00439.x","article-title":"Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin-diabetic rats","volume":"22","author":"Y Aizu","year":"2002","journal-title":"Neuropathology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1167\/iovs.08-1973","article-title":"Efficacy of Rho-kinase inhibition in promoting cell survival and reducing reactive gliosis in the rodent retina","volume":"50","author":"A Tura","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nm1585","article-title":"TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1","volume":"13","author":"A Amadi-Obi","year":"2007","journal-title":"Nat Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"8693","DOI":"10.1523\/JNEUROSCI.20-23-08693.2000","article-title":"Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells","volume":"20","author":"G Tezel","year":"2000","journal-title":"J Neurosci"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/mt.2009.112","article-title":"AAV-mediated tyrosinase gene transfer restores melanogenesis and retinal function in a model of oculo-cutaneous albinism type I (OCA1)","volume":"17","author":"A Gargiulo","year":"2009","journal-title":"Mol Ther"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12177-009-9026-6","article-title":"The two sides of cytokine signaling and glaucomatous optic neuropathy","volume":"2","author":"P Huang","year":"2009","journal-title":"J Ocul Biol Dis Infor"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/clim.1999.4701","article-title":"Expression of interferon-gamma in the lens exacerbates anterior uveitis and induces retinal degenerative changes in transgenic Lewis rats","volume":"91","author":"CE Egwuagu","year":"1999","journal-title":"Clin Immunol"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Chatterjee S, Eby J, Al-Khami AA, Soloshchenko M, Kang HK, <etal>et al<\/etal>.. (2013) A Quantitative Increase in Regulatory T Cells Controls Development of Vitiligo. J Invest Dermatol. (In Press).","DOI":"10.1038\/jid.2013.540"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"8442","DOI":"10.1167\/iovs.11-8152","article-title":"Neurodegenerative and Inflammatory Pathway Components Linked to TNF-alpha\/TNFR1 Signaling in the Glaucomatous Human Retina","volume":"52","author":"X Yang","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1098-1136(200010)32:1<42::AID-GLIA40>3.0.CO;2-3","article-title":"Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head","volume":"32","author":"L Yuan","year":"2000","journal-title":"Glia"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.exer.2009.02.005","article-title":"Immunoregulation of retinal ganglion cell fate in glaucoma","volume":"88","author":"MB Wax","year":"2009","journal-title":"Exp Eye Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00055735-200404000-00003","article-title":"The immune system and glaucoma","volume":"15","author":"G Tezel","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/IJG.0b013e318156a592","article-title":"Autoimmunity and glaucoma","volume":"17","author":"FH Grus","year":"2008","journal-title":"J Glaucoma"},{"key":"ref46","first-page":"774","article-title":"Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis","volume":"36","author":"HA Quigley","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-4835(95)80056-5","article-title":"Programmed cell death of retinal ganglion cells during experimental glaucoma","volume":"61","author":"E Garcia-Valenzuela","year":"1995","journal-title":"Exp Eye Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archopht.1997.01100160201010","article-title":"TUNEL-positive ganglion cells in human primary open-angle glaucoma","volume":"115","author":"LA Kerrigan","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0002-9394(00)00862-X","article-title":"T cell subsets and sIL-2R\/IL-2 levels in patients with glaucoma","volume":"131","author":"J Yang","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/02713680701375183","article-title":"Antibodies to alpha B-crystallin, vimentin, and heat shock protein 70 in aqueous humor of patients with normal tension glaucoma and IgG antibody patterns against retinal antigen in aqueous humor","volume":"32","author":"SC Joachim","year":"2007","journal-title":"Curr Eye Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI2425","article-title":"Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin","volume":"102","author":"AJ Barber","year":"1998","journal-title":"J Clin Invest"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.2337\/db05-1635","article-title":"Diabetic retinopathy: seeing beyond glucose-induced microvascular disease","volume":"55","author":"DA Antonetti","year":"2006","journal-title":"Diabetes"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/BF00400249","article-title":"Impaired visual evoked potential and primary axonopathy of the optic nerve in the diabetic BB\/W-rat","volume":"35","author":"AA Sima","year":"1992","journal-title":"Diabetologia"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000323942","article-title":"Mixed vascular occlusion in a patient with interferon-associated retinopathy","volume":"2","author":"BJ Bajaire","year":"2011","journal-title":"Case Rep Ophthalmol"},{"key":"ref55","first-page":"238","article-title":"Development of neovascular glaucoma in the course of interferon alfa therapy for hepatitis type C. Br J Ophthalmol","volume":"78","author":"M Ayaki","year":"1994"},{"key":"ref56","first-page":"134","article-title":"Development of glaucoma in the course of interferon alpha therapy for chronic hepatitis B. Yonsei Med J","volume":"42","author":"YS Kwon","year":"2001"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"284","DOI":"10.5301\/ejo.5000037","article-title":"Combined central retinal vein and central retinal artery occlusions and neovascular glaucoma associated with interferon treatment","volume":"22","author":"AV Rachitskaya","year":"2012","journal-title":"Eur J Ophthalmol"},{"key":"ref58","first-page":"431","article-title":"Expression profile of inflammatory cytokines in aqueous from glaucomatous eyes","volume":"18","author":"J Chua","year":"2012","journal-title":"Mol Vis"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/bjo.2006.101485","article-title":"Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs","volume":"91","author":"L Malvitte","year":"2007","journal-title":"Br J Ophthalmol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0089392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T18:07:02Z","timestamp":1716574022000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0089392"}},"subtitle":[],"editor":[{"given":"Shama","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,28]]},"references-count":59,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0089392","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,28]]}}}